Prime Healthcare

HEALTH TECHNOLOGY

Modern Healthcare | October 19, 2021

Modern Healthcare, a Crain Communications brand, is pleased to announce the launch of Digital Health Business & Technology, a digital media brand that covers the latest news, data and insights on all aspects of digital healthcare technologies, from hardware, software products and services to finance, investment and mergers and acquisitions activity. The new digital brand leverages the editorial expertise of Modern Healthcare, an industry-leading provider of heal...

HEALTH TECHNOLOGY

proteanTecs | December 23, 2021

proteanTecs, a leading developer of deep data analytics solutions for electronics health and performance monitoring, announced today it has won the 2021 Frost & Sullivan Best Practices Award for Global Electronics Health Monitoring Technology Innovation Leadership.Electronics have become an existential enabler for key industries, from Datacenter to Automotive, where 24/7 continuity with zero in-mission failures is pivotal. Therefore, it is necessary to guarantee these systems' reliabi...

HEALTH TECHNOLOGY

GE Healthcare | November 29, 2021

At the Radiological Society of North America’s (RSNA) 2021 Annual Meeting, GE Healthcare unveiled around 60 innovative technology solutions spanning the healthcare spectrum including patient screening, diagnostics, therapy planning, guidance, and monitoring. Amidst a global pandemic and mounting pressure on the industry, the company accelerated innovations underpinned by artificial intelligence (AI) and digital solutions to help transform healthcare delivery, making it easier and more e...

FUTURE OF HEALTHCARE

Medicago | May 06, 2022

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...